Ki-67 Cancer Research Results
Ki-67, Ki-67 protein: Click to Expand ⟱
| Source: |
| Type: proliferation marker |
A high Ki-67 proliferation index means many cells are dividing quickly and that the cancer is likely to grow and spread.
Markers of proliferation index (Ki-67)
• Ki-67 serves primarily as a proliferation marker: higher levels are generally indicative of aggressive disease and poorer outcomes across many cancer types.
• While Ki-67 itself is not considered a driver of tumorigenesis, its expression mirrors the high proliferative activity associated with protumoral behavior.
• It is widely used in clinical practice to aid in tumor grading, prognostication, and treatment planning.
|
Nor, Normal Healthy: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
*Inflam↑, *cardioP↑, *angioG↓, *antiOx↑, *neuroP↑, *Bacteria↓, AntiTum↑, TumCG↓, TumCMig↓, TumCI↓, Apoptosis↑, E-cadherin↑, NF-kB↓, TumCCA↑, cycD1/CCND1↓, PCNA↓, Ki-67↓, MMP2↓, MMP7↓, MMP9↓, TumCG↓, Casp3↑, NF-kB↓, Akt↓, mTOR↓, LDH↓, Ca+2↑, eff↑, *toxicity↓, *BioAv↝, *PGE2↓, *TLR2↓, *TLR4↓, *MAPK↓, *PPARγ↓,
| - |
in-vitro, |
GC, |
SNU16 |
|
|
|
- |
in-vitro, |
Nor, |
GES-1 |
|
|
|
TumCP↓, Apoptosis↑, BAX↑, BAD↑, Cyt‑c↑, cl‑PARP↑, cl‑Casp3↑, Bcl-2↓, Bcl-xL↓, p‑PI3K↓, p‑Akt↓, Ki-67↓, toxicity↓, RadioS↑,
| - |
in-vitro, |
OS, |
143B |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
- |
in-vivo, |
OS, |
NA |
|
|
|
AntiCan↑, *toxicity∅, Ferroptosis↑, ROS↑, lipid-P↑, GSH↓, p62↑, SLC12A5↓, eff↓, GPx4↓, i-Iron↑, eff↓, MDA↑, TumVol↓, TumW↓, Ki-67↓, LC3B↑, *Weight∅,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Ferroptosis↑, 1, GPx4↓, 1, GSH↓, 1, i-Iron↑, 1, lipid-P↑, 1, MDA↑, 1, ROS↑, 1,
Core Metabolism/Glycolysis ⓘ
LDH↓, 1,
Cell Death ⓘ
Akt↓, 1, p‑Akt↓, 1, Apoptosis↑, 2, BAD↑, 1, BAX↑, 1, Bcl-2↓, 1, Bcl-xL↓, 1, Casp3↑, 1, cl‑Casp3↑, 1, Cyt‑c↑, 1, Ferroptosis↑, 1,
Autophagy & Lysosomes ⓘ
LC3B↑, 1, p62↑, 1,
DNA Damage & Repair ⓘ
cl‑PARP↑, 1, PCNA↓, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
mTOR↓, 1, p‑PI3K↓, 1, TumCG↓, 2,
Migration ⓘ
Ca+2↑, 1, E-cadherin↑, 1, Ki-67↓, 3, MMP2↓, 1, MMP7↓, 1, MMP9↓, 1, TumCI↓, 1, TumCMig↓, 1, TumCP↓, 1,
Barriers & Transport ⓘ
SLC12A5↓, 1,
Immune & Inflammatory Signaling ⓘ
NF-kB↓, 2,
Drug Metabolism & Resistance ⓘ
eff↓, 2, eff↑, 1, RadioS↑, 1,
Clinical Biomarkers ⓘ
Ki-67↓, 3, LDH↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, AntiTum↑, 1, toxicity↓, 1, TumVol↓, 1, TumW↓, 1,
Total Targets: 49
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1,
Core Metabolism/Glycolysis ⓘ
PPARγ↓, 1,
Cell Death ⓘ
MAPK↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↑, 1, PGE2↓, 1, TLR2↓, 1, TLR4↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↝, 1,
Functional Outcomes ⓘ
cardioP↑, 1, neuroP↑, 1, toxicity↓, 1, toxicity∅, 1, Weight∅, 1,
Infection & Microbiome ⓘ
Bacteria↓, 1,
Total Targets: 15
Scientific Paper Hit Count for: Ki-67, Ki-67 protein
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:425 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page